Synthesis of Novel 9-Benzyl-3-methylene-1,5-bis(p-toluenesulfonyl)-1,5,9-triazacyclododecane (CADA) Analogs
Loading...
Authors
Anugu, Sreenivasa R.
Issue Date
2009
Type
Dissertation
Language
Keywords
AIDS , antiviral , CADA , CD4 downmodulation , HIV , organic synthesis
Alternative Title
Abstract
Cyclotriazadisulfonamide (CADA) inhibits the entry of HIV and HHV-7
by specific down-modulation of the CD4 receptor expression on the surface of
lymphocytes and monocytes/macrophages. In this work synthesis and biological
activities of novel CADA head group analogs SA01, SA02, SA03, SA04, SA06,
SA07, SA08, SA40, SA41 with polar and good leaving groups are reported. The
structural modifications of CADA were made to increase potency, reduce
cytotoxicity, and improve physical properties. IsoCADA (SA05), an isomer of
CADA, was synthesized involving cyclization of 1,5,7-triazabicyclo[4.4.0]dec-5-
ene (TBD), a guanidinium base, and tested for its antiviral properties. An alternate
method for the macrocyclization of disulfonamide using a palladium catalyst has
been successfully developed. This new method obviates the necessity of high
dilution, slow addition of the reagent and formation of polymer side products which
have limited the synthetic utility of the classical Richman-Atkins macrocyclization
method.
Description
Citation
Publisher
License
In Copyright(All Rights Reserved)